Related references
Note: Only part of the references are listed.Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria
Shazad Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China
P. Zhang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
The Global Ascendency of OXA-48-Type Carbapenemases
Johann D. D. Pitout et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases
J. M. Kidd et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa
Bartolome Moya et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria
Shazad Mushtaq et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K-pneumoniae
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2019)
In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
Christopher Frohlich et al.
MSPHERE (2019)
In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from US and European Hospitals during 2014-2015
Ian Morrissey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018
Kati Raisanen et al.
EUROSURVEILLANCE (2019)
Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens
Anjali Y. Bhagirath et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Rapidly disseminating blaOXA-232 carrying Klebsiella pneumoniae belonging to ST231 in India: multiple and varied mobile genetic elements
Chaitra Shankar et al.
BMC MICROBIOLOGY (2019)
The Role of the Ω-Loop in Regulation of the Catalytic Activity of TEM-Type β-Lactamases
Alexey Egorov et al.
BIOMOLECULES (2019)
Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens
Kenneth S. Thomson et al.
ANTIBIOTICS-BASEL (2019)
In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015
Krystyna M. Kazmierczak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Selection of mutants with resistance or diminished susceptibility to ceftazidime/avibactam from ESBL-and AmpC-producing Enterobacteriaceae
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa
Adnan Alatoom et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate
Anna Both et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae
Olga Lomovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae
Ghady Haidar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases
Ghady Haidar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
CLINICAL INFECTIOUS DISEASES (2016)
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
In Vitro Selection of Ceftazidime-Avibactam Resistance in Enterobacteriaceae with KPC-3 Carbapenemase
David M. Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Role of Novel Multidrug Efflux Pump Involved in Drug Resistance in Klebsiella pneumoniae
Vijaya Bharathi Srinivasan et al.
PLOS ONE (2014)
OXA-48-like carbapenemases: the phantom menace
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Klebsiella pneumoniae Outer Membrane Porins OmpK35 and OmpK36 Play Roles in both Antimicrobial Resistance and Virulence
Yu-Kuo Tsai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands
Jayant S. Kalpoe et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Efflux-Mediated Drug Resistance in Bacteria An Update
Xian-Zhi Li et al.
DRUGS (2009)
Pharmacokinetics and Pharmacodynamics of Antibacterial Agents
Matthew E. Levison et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Spread of OXA-48-Positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey
Amelie Carrer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Cefepime: a reappraisal in an era of increasing antimicrobial resistance
Andrea Endimiani et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
G. L. Drusano
EUROPEAN RESPIRATORY REVIEW (2007)
Share Paper
